Camlin Fine Sciences Limited

CAMLINFINE.BO · Bombay Stock Exchange · INR

78,61INR

+1,04 (+1,34 %)Stand 9. Nov., 9:59

Vortag 77,57

Kennzahlen

Eröffnung
77,78
Vortag
77,57
Tagesspanne
76,51 – 79,12
52 Wochen
73,50 – 192,00
Volumen
60.645
Ø Volumen
61.936
Börsenwert
15,09 Mrd. INR
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
0,7
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Camlin Fine Sciences Limited, along with its subsidiaries, is actively engaged globally in the research, development, manufacturing, and distribution of specialized chemical products, functional ingredients, and additive blends. The company provides a comprehensive portfolio of shelf-life extension solutions, marketed under its Xtendra and NaSure brands. These solutions feature a variety of antioxidants, including synthetic compounds like Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate, as well as plant-derived options such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract. Furthermore, their offerings encompass mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters. Beyond shelf-life solutions, Camlin Fine Sciences also supplies aroma ingredients like vanillin and ethyl vanillin, pharmaceutical and nutraceutical substances sourced through fermentation and plant extraction, and performance chemicals including hydroquinone and catechol. Its diverse product range serves a wide array of industries, including food and beverage, pet food and animal nutrition, rendering, aquaculture, petrochemical, pharmaceutical, agrochemical, dyes and pigment, biofuel, aroma technical, fragrance, and flavor sectors. Founded in 1931 and based in Mumbai, India, the company operated as Camlin Fine Chemicals Limited until its rebranding to Camlin Fine Sciences Limited in August 2011.

CEO
Ashish Subhash Dandekar
Mitarbeitende
624
Hauptsitz
Mumbai, MA, IN
Sektor
Basic Materials
Branche
Chemicals - Specialty
Börsengang
30. März 2007

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.